AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: SLOVIN SF SCHER HI DIVGI CR REUTER V SGOUROS G MOORE M WEINGARD K PETTENGALL R IMBRIACO M ELSHIRBINY A FINN R BRONSTEIN J BRETT C MILENIC D DNISTRIAN A SHAPIRO L SCHLOM J LARSON SM
Citation: Sf. Slovin et al., INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(3), 1998, pp. 643-651
INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: SLOVIN SF SCHER HI DIVGI CR REUTER V SGOUROS G MOORE M WEINGARD K PETTENGALL R IMBRIACO M ELSHIRBINY A FINN R BRONSTEIN J BRETT C MILENIC D DNISTRIAN A SHAPIRO L SCHLOM J LARSON SM
Citation: Sf. Slovin et al., INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(3), 1998, pp. 643-651
PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/
Authors: DIVGI CR BANDER NH SCOTT AM ODONOGHUE JA SGOUROS G WELT S FINN RD MORRISSEY F CAPITELLI P WILLIAMS JM DELAND D NAKHRE A OOSTERWIJK E GULEC S GRAHAM MC LARSON SM OLD LJ
Citation: Cr. Divgi et al., PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/, Clinical cancer research, 4(11), 1998, pp. 2729-2739
RAPID AND SPECIFIC TARGETING OF MONOCLONAL-ANTIBODY A33 TO A COLON-CANCER XENOGRAFT IN NUDE-MICE
Authors: BARENDSWAARD EC SCOTT AM DIVGI CR WILLIAMS C COPLAN K RIEDEL E YAO TJ GANSOW OA FINN RD LARSON SM OLD LJ WELT S
Citation: Ec. Barendswaard et al., RAPID AND SPECIFIC TARGETING OF MONOCLONAL-ANTIBODY A33 TO A COLON-CANCER XENOGRAFT IN NUDE-MICE, International journal of oncology, 12(1), 1998, pp. 45-53
PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS
Authors: LOH A SGOUROS G ODONOGHUE JA DELAND D PURI D CAPITELLI P HUMM JL LARSON SM OLD LJ DIVGI CR
Citation: A. Loh et al., PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS, The Journal of nuclear medicine, 39(3), 1998, pp. 484-489
ALL OF THE ABOVE (WITH CAVEATS FOR EACH)
Authors: DIVGI CR
Citation: Cr. Divgi, ALL OF THE ABOVE (WITH CAVEATS FOR EACH), The Journal of nuclear medicine, 39(1), 1998, pp. 42-43
THE DESIGN OF A RAPID FRACTIONATION TREATMENT PROTOCOL FOR RADIOIMMUNOTHERAPY
Authors: ODONOGHUE JA SGOUROS G LOH AC DIVGI CR HUMM JL
Citation: Ja. Odonoghue et al., THE DESIGN OF A RAPID FRACTIONATION TREATMENT PROTOCOL FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 442-442
G250 ANTIBODY PHARMACOKINETIC PARAMETERS FOR A MODEL OF TUMOR RESPONSE IN RADIOIMMUNOTHERAPY
Authors: SGOUROS G LOH AC ODONOGHUE JA DELAND D PURI D CAPITELLI P HUMM JL LARSON SM OLD LJ DIVGI CR
Citation: G. Sgouros et al., G250 ANTIBODY PHARMACOKINETIC PARAMETERS FOR A MODEL OF TUMOR RESPONSE IN RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 975-975
MARROW AND WHOLE-BODY ABSORBED DOSE VS MARROW TOXICITY FOLLOWING I-131 G250 ANTIBODY THERAPY IN PATIENTS WITH RENAL-CELL CARCIONOMA
Authors: SGOUROS G DELAND D LOH AC DIVGI CR LARSON SM
Citation: G. Sgouros et al., MARROW AND WHOLE-BODY ABSORBED DOSE VS MARROW TOXICITY FOLLOWING I-131 G250 ANTIBODY THERAPY IN PATIENTS WITH RENAL-CELL CARCIONOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 1064-1064
JOD-BASEDOW-SYNDROME FOLLOWING ORAL IODINE AND RADIOIODINATED-ANTIBODY ADMINISTRATION
Authors: ELSHIRBINY AM STAVROU SS DNISTRIAN A SONENBERG M LARSON SM DIVGI CR
Citation: Am. Elshirbiny et al., JOD-BASEDOW-SYNDROME FOLLOWING ORAL IODINE AND RADIOIODINATED-ANTIBODY ADMINISTRATION, The Journal of nuclear medicine, 38(11), 1997, pp. 1816-1817
SINGLE-CHAIN ANTIGEN-BINDING PROTEIN (SFV CC49) - FIRST HUMAN STUDIESIN COLORECTAL-CARCINOMA METASTATIC TO LIVER
Authors: LARSON SM ELSHIRBINY AM DIVGI CR SGOUROS G FINN RD TSCHMELITSCH J PICON A WHITLOW M SCHLOM J ZHANG JJ COHEN AM
Citation: Sm. Larson et al., SINGLE-CHAIN ANTIGEN-BINDING PROTEIN (SFV CC49) - FIRST HUMAN STUDIESIN COLORECTAL-CARCINOMA METASTATIC TO LIVER, Cancer, 80(12), 1997, pp. 2458-2468
CORRELATION OF THE FINDINGS OF TL-201 CHLORIDE SCANS WITH THOSE OF OTHER IMAGING MODALITIES AND HISTOLOGY FOLLOWING THERAPY IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMAS (VOL 23, PG 1558, 1996)
Authors: KOSTAKOGLU L PANICEK DM DIVGI CR BOTET J HEALY J LARSON SM ABDELDAYEM HM
Citation: L. Kostakoglu et al., CORRELATION OF THE FINDINGS OF TL-201 CHLORIDE SCANS WITH THOSE OF OTHER IMAGING MODALITIES AND HISTOLOGY FOLLOWING THERAPY IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMAS (VOL 23, PG 1558, 1996), European journal of nuclear medicine, 23(11), 1996, pp. 1558-1558
HEMATOLOGIC TOXICITY IN RADIOIMMUNOTHERAPY - AN EVALUATION OF DIFFERENT PREDICTIVE MEASURES
Authors: SGOUROS G DIVGI CR SCOTT AM WILLIAMS J LARSON SM
Citation: G. Sgouros et al., HEMATOLOGIC TOXICITY IN RADIOIMMUNOTHERAPY - AN EVALUATION OF DIFFERENT PREDICTIVE MEASURES, The Journal of nuclear medicine, 37(5), 1996, pp. 165-165
RADIOLABELED MONOCLONAL-ANTIBODY IMAGING IN CANCER - POTENTIAL AND LIMITATIONS
Authors: DIVGI CR
Citation: Cr. Divgi, RADIOLABELED MONOCLONAL-ANTIBODY IMAGING IN CANCER - POTENTIAL AND LIMITATIONS, CLINICAL IMMUNOTHERAPEUTICS, 3(3), 1995, pp. 218-226
PILOT RADIOIMMUNOTHERAPY TRIAL WITH I-131-LABELED MURINE MONOCLONAL-ANTIBODY CC49 AND DEOXYSPERGUALIN IN METASTATIC COLON-CARCINOMA
Authors: DIVGI CR SCOTT AM GULEC S BROUSSARD EK LEVY N YOUNG C CAPITELLI P DAGHIGHIAN F WILLIAMS JM FINN RD KEMENY N HILTON S KELSEN D MILENIC DE LORA ME SCHLOM J LARSON SM
Citation: Cr. Divgi et al., PILOT RADIOIMMUNOTHERAPY TRIAL WITH I-131-LABELED MURINE MONOCLONAL-ANTIBODY CC49 AND DEOXYSPERGUALIN IN METASTATIC COLON-CARCINOMA, Clinical cancer research, 1(12), 1995, pp. 1503-1510
IN-VIVO IMAGING AND SPECIFIC TARGETING OF P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT NUDE-MICE XENOGRAFTS WITH [I-125] MRK-16 MONOCLONAL-ANTIBODY
Authors: SCOTT AM ROSA E MEHTA BM DIVGI CR FINN RD BIEDLER JL TSURUO T KALAIGIAN H LARSON SM
Citation: Am. Scott et al., IN-VIVO IMAGING AND SPECIFIC TARGETING OF P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT NUDE-MICE XENOGRAFTS WITH [I-125] MRK-16 MONOCLONAL-ANTIBODY, Nuclear medicine and biology, 22(4), 1995, pp. 497-504
CORRELATION OF THE FINDINGS OF TL-201 CHLORIDE SCANS WITH THOSE OF OTHER IMAGING MODALITIES AND HISTOLOGY FOLLOWING THERAPY IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMAS
Authors: KOSTAKOGLU L PANICEK DM DIVGI CR BOTET J HEALY J LARSON SM ABDELDAYEM HM
Citation: L. Kostakoglu et al., CORRELATION OF THE FINDINGS OF TL-201 CHLORIDE SCANS WITH THOSE OF OTHER IMAGING MODALITIES AND HISTOLOGY FOLLOWING THERAPY IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMAS, European journal of nuclear medicine, 22(11), 1995, pp. 1232-1237
PHASE-I RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-CC49 IN METASTATIC COLON-CARCINOMA
Authors: DIVGI CR SCOTT AM DANTIS L CAPITELLI P SILER K HILTON S FINN RD KEMENY N KELSEN D KOSTAKOGLU L SCHLOM J LARSON SM
Citation: Cr. Divgi et al., PHASE-I RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-CC49 IN METASTATIC COLON-CARCINOMA, The Journal of nuclear medicine, 36(4), 1995, pp. 586-592
LOCALIZATION OF COMPLEMENT-FIXING CYTOTOXIC MONOCLONAL-ANTIBODIES TO SUBCUTANEOUS TUMORS AND LIVER METASTASES IN A SYNGENEIC IMMUNOCOMPETENT RAT COLON-CARCINOMA MODEL
Authors: OBOYLE KP MATTES MJ SIGURDSON ER SUTANTOWARD E DIVGI CR WELT S WRIGHT KE
Citation: Kp. Oboyle et al., LOCALIZATION OF COMPLEMENT-FIXING CYTOTOXIC MONOCLONAL-ANTIBODIES TO SUBCUTANEOUS TUMORS AND LIVER METASTASES IN A SYNGENEIC IMMUNOCOMPETENT RAT COLON-CARCINOMA MODEL, Journal of immunotherapy with emphasis on tumor immunology, 15(3), 1994, pp. 175-184
RADIOIMMUNODETECTION OF COLORECTAL-CANCER
Authors: SCOTT AM LARSON SM DIVGI CR WELT S
Citation: Am. Scott et al., RADIOIMMUNODETECTION OF COLORECTAL-CANCER, Diagnostic oncology, 4(2-3), 1994, pp. 115-122
GALLIUM-67-CITRATE IMAGING IN NUCLEAR ONCOLOGY
Authors: MACAPINLAC HA SCOTT AM LARSON SM DIVGI CR YEH SDJ GOLDSMITH SJ
Citation: Ha. Macapinlac et al., GALLIUM-67-CITRATE IMAGING IN NUCLEAR ONCOLOGY, Nuclear medicine and biology, 21(5), 1994, pp. 731-738
CLINICAL-APPLICATIONS OF FUSION IMAGING IN ONCOLOGY
Authors: SCOTT AM MACAPINLAC H ZHANG JJ KALAIGIAN H GRAHAM MC DIVGI CR SGOUROS G GOLDSMITH SJ LARSON SM
Citation: Am. Scott et al., CLINICAL-APPLICATIONS OF FUSION IMAGING IN ONCOLOGY, Nuclear medicine and biology, 21(5), 1994, pp. 775-784
CURRENT STATUS OF RADIOIMMUNOTHERAPY
Authors: LARSON SM DIVGI CR SCOTT A SGOUROS G GRAHAM MC KOSTAKOGLU L SCHEINBERG D CHEUNG NKV SCHLOM J FINN RD
Citation: Sm. Larson et al., CURRENT STATUS OF RADIOIMMUNOTHERAPY, Nuclear medicine and biology, 21(5), 1994, pp. 785-792
CLINICAL COMPARISON OF RADIOLOCALIZATION OF 2 MONOCLONAL-ANTIBODIES (MABS) AGAINST THE TAG-72 ANTIGEN
Authors: DIVGI CR SCOTT AM MCDERMOTT K FALLONE PS HILTON S SILER K CARMICHAEL N DAGHIGHIAN F FINN RD COHEN AM SCHLOM J LARSON SM
Citation: Cr. Divgi et al., CLINICAL COMPARISON OF RADIOLOCALIZATION OF 2 MONOCLONAL-ANTIBODIES (MABS) AGAINST THE TAG-72 ANTIGEN, Nuclear medicine and biology, 21(1), 1994, pp. 9-15
PRESELECTION OF PATIENTS WITH HIGH TAG-72 ANTIGEN EXPRESSION LEADS TOTARGETING OF 94-PERCENT OF KNOWN METASTATIC TUMOR SITES WITH MONOCLONAL-ANTIBODY I-131 CC49
Authors: KOSTAKOGLU L DIVGI CR HILTON S CORDONCARDO C SCOTT AM KALAIGIAN H FINN RD SCHLOM J LARSON SM
Citation: L. Kostakoglu et al., PRESELECTION OF PATIENTS WITH HIGH TAG-72 ANTIGEN EXPRESSION LEADS TOTARGETING OF 94-PERCENT OF KNOWN METASTATIC TUMOR SITES WITH MONOCLONAL-ANTIBODY I-131 CC49, Cancer investigation, 12(6), 1994, pp. 551-558
Risultati: 1-25 | 26-50